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An evaluation of the self‑assembly 
enhancing properties 
of cell‑derived hexameric 
amyloid‑β
Devkee M. Vadukul1,4, Céline Vrancx1, Pierre Burguet2, Sabrina Contino1, Nuria Suelves1, 
Louise C. Serpell3, Loïc Quinton2 & Pascal Kienlen‑Campard1*
A key hallmark of Alzheimer’s disease is the extracellular deposition of amyloid plaques composed 
primarily of the amyloidogenic amyloid‑β (Aβ) peptide. The Aβ peptide is a product of sequential 
cleavage of the Amyloid Precursor Protein, the first step of which gives rise to a C‑terminal Fragment 
(C99). Cleavage of C99 by γ‑secretase activity releases Aβ of several lengths and the Aβ42 isoform in 
particular has been identified as being neurotoxic. The misfolding of Aβ leads to subsequent amyloid 
fibril formation by nucleated polymerisation. This requires an initial and critical nucleus for self‑
assembly. Here, we identify and characterise the composition and self‑assembly properties of cell‑
derived hexameric Aβ42 and show its assembly enhancing properties which are dependent on the Aβ 
monomer availability. Identification of nucleating assemblies that contribute to self‑assembly in this 
way may serve as therapeutic targets to prevent the formation of toxic oligomers.
Alzheimer’s disease (AD) is a neurodegenerative disease characterised by the deposition of extracellular amyloid 
plaques in the brain which are primarily composed of the self-assembled amyloid-β (Aβ)  peptide1. The self-
assembly process of Aβ has been the focus of much research, however, it is still unclear how this relates to disease 
pathology. Aβ is a product of sequential cleavage of the Amyloid Precursor Protein (APP) in the amyloidogenic 
pathway where APP is first cleaved by β-secretase at the N-terminus of Aβ. The two products of this are soluble 
APP-β (sAPPβ) and a C-terminal fragment (CTF) consisting of 99 amino acids (C99). C99 is further cleaved 
by γ-secretase, beginning with a proteolytic cut at the ε site, to free the C-terminal APP intracellular domain 
(AICD), and release Aβ of varying lengths ranging from Aβ49-382–4.
Although extracellular Aβ plaques found in AD brains are primarily composed of highly ordered cross-β 
mature amyloid  fibrils5–7, soluble forms of Aβ have shown a much greater correlation with cognitive decline and 
neurodegeneration in AD  patients8,9. Due to this, it is now widely accepted that pre-fibrillar spherical/globular 
Aβ oligomers are neurotoxic entities. In particular, several Aβ42 oligomers of different assembly sizes and con-
formations have been identified as being  cytotoxic7,10–18.
Oligomers are formed as intermediary assemblies during amyloid formation, the mechanism of which is via 
nucleated  polymerisation19. There is first the nucleation or lag phase where the monomer precursor is either in 
an unfolded, partially folded or natively folded state and undergoes usually unfavourable self-association to form 
nuclei that are critical for further self-assembly20. This critical nucleus is defined as the smallest assembly size that 
grows faster by the addition of monomers, than dissociates back to smaller assemblies including  monomers21. 
Once the critical nucleus has been formed, there is a rapid formation of fibrils by the addition of monomers. This 
is the elongation phase and fibril formation in this way is known as primary nucleation. The formation of these 
nuclei is therefore crucial in the generation of amyloid and the identification of these structures will ultimately 
aid our understanding of amyloid assembly and pathology.
One likely nucleus of Aβ42 assembly has been suggested to be a hexameric  assembly20,22–26. It has been shown 
that the formation of hexameric Aβ42 is an early event in the self-assembly  pathway23,24,27,28 and the identification 
of several multimers of hexamers e.g. Aβ derived diffusible ligands (ADDLs), Aβ*56 and globulomers, provide a 
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compelling argument that the hexamer is the basic building block for the formation of toxic  oligomers15,29. The 
majority of these studies investigating the role of hexameric Aβ42 as a nucleus for self-assembly make use of 
synthetic peptides which are greatly advantageous due to being readily available at high concentrations necessary 
for biophysical and structural characterisation. However, the true cellular environment and processing of C99 
to release Aβ cannot be mimicked using these synthetic peptides.
Furthermore, familial AD (FAD) causing mutations within the Aβ sequence, which are also in the extracel-
lular domain of the C99 sequence, have been shown to have a higher aggregation propensity in previous studies 
using synthetic and recombinant  proteins30–38. It is not yet understood whether these FAD mutations which 
promote self-assembly, increase overall Aβ production, and/or change biochemical properties, also promote/
enhance the formation of hexameric Aβ assemblies.
Here, by transfection of Chinese Hamster Ovarian (CHO) cells, we identify the formation of hexamers in Aβ 
enriched conditions. We also identify for the first time, the formation of hexameric Aβ in CHO transfected with 
the Flemish (A21G), Dutch (E22Q), Italian (E22K), Arctic (E22G) and Iowa (D23N) FAD causing  mutations39–42. 
We have isolated cell-derived hexameric Aβ assemblies and assessed their composition, self-assembly propensity 
and potential nucleating properties using complementary techniques including Mass Spectroscopy, Thioflavin T 
(ThT) fluorescence and immunoblotting. We identify these cell-derived Aβ hexamers as Aβ42 assemblies which 
are likely contributing nuclei for the self-assembly of Aβ monomers. This effect is much more pronounced on 
monomeric Aβ42 than Aβ40 and is highly dependent on the concentration of available monomers. Furthermore, 
we show for the first time in a cellular context that the formation of this hexamer is an inherent property of the 
Aβ42 peptide and its self-assembly propensity, as a self-assembly impaired primary sequence variant of Aβ42 does 
not form hexamers. The identification of assemblies nucleating Aβ self-assembly in this way provides potential 
therapeutic targets to prevent oligomer-induced neurotoxicity.
Results
Aβ assembly profile in CHO cells: identification of hexameric Aβ. Although Aβ self-assembly has 
been extensively studied with synthetic peptides, less is known about the assembly of Aβ peptides produced in a 
cellular context. As C99 processing precedes Aβ release in physiology, we first assessed the Aβ assembly profile 
in CHO cells transfected with the human C99 sequence affixed with the signal peptide of the full-length APP in 
a pSVK3 plasmid backbone. Cell lysates and media of CHO cells were harvested 48 h after transfection and the 
Aβ profile was assessed by western blotting and detected using the monoclonal human specific anti-Aβ W0-2 
antibody (Fig. 1a). In line with what has previously been shown by our group, we confirm that cells transfected 
with C99 produce a detectable band corresponding to an Aβ assembly size of ~ 28 kDa; the theoretical size of 
an Aβ42  hexamer43. Detection with the anti-Cter antibody against the C-terminal of APP did not identify these 
bands, consolidating these assemblies are likely to be Aβ and do not contain the CTF of C99 (Supplemental 
Figure S1). Furthermore, as the band was not detected in the Empty Plasmid (EP) condition, we are confident 
that the hexamer is not a product of the transfection protocol. Whilst only Aβ hexamers were detected in the 
cell lysates of these cells, monomers, dimers, trimers and hexamers were detected in the media confirming that 
in our cellular model, C99 is cleaved to release Aβ detectable both intra- and extracellularly (Fig. 1a). Addition-
ally, we also assessed the Aβ profile of cells transfected with the Aβ40 and Aβ42 sequences affixed with the APP 
signal peptide (referred to as C40 and C42 respectively), to understand whether the formation of this hexamer in 
a cellular context was related to one or both of these Aβ isoforms (Fig. 1b). We do not identify a hexameric band 
in the cell lysates or culture media of C40 transfected CHO cells, which would be ~ 26 kDa in size, in line with 
the preferential formation of hexamers by Aβ42 previously shown with synthetic  peptides23. The identification 
of a hexameric band both intra- and extracellularly in C42 transfected CHO cells suggests that (1) formation 
of hexameric Aβ is irrespective of whether there is first the processing of the C99 fragment and (2) cell-derived 
hexamer formation is likely to be an intrinsic property of the Aβ42 sequence itself, as has been demonstrated 
previously with synthetic  peptides23,26,27. Finally, as pentamers/hexamers have been suggested to be artifacts 
of  SDS44, we confirmed the presence of detectable Aβ hexamers in synthetic Aβ42 preparations as well as cell 
lysates and culture media of C42 transfected CHO cells in native conditions. The samples were harvested and 
analysed by western blotting in SDS-free conditions and detected with the W0-2 antibody (Supplemental Fig-
ure S2a). The same band was not detected by the anti-Cter antibody for cell lysates and culture media samples, as 
well as synthetic Aβ preparations (Supplemental Figure S2b). Importantly, this enforces our hypothesis that the 
Aβ hexamer is a relevant oligomeric assembly and not an artifact of experimental conditions.
To link the formation of hexameric Aβ assembly to disease related conditions, we investigated the Aβ pro-
file in CHO cells transfected with the C99 sequence containing the A21G, E22Q, E22K, E22G and D23N FAD 
Figure 1.  Aβ profile in transfected CHO cells detected with the anti-Aβ W0-2 antibody. (a, left panel) Hexamer 
formation is seen in cell lysates of CHO cells transfected with C99. (a, right panel) Monomers (M), Dimers 
(D), Trimers (T) and Hexamers (H), were detected in the culture media of C99 transfected CHO cells. (b, left 
panel) No assemblies were detected in the cell lysates of C40 transfected CHO cells, however, hexameric Aβ was 
detected in cell lysates of C42 transfected CHO cells. (b, right panel) Hexameric Aβ is also detected in culture 
media of CHO cells transfected with C42 only. (c) Hexameric Aβ is detected in cell lysates and media of CHO 
cells transfected with FAD mutations in the C99 sequence. Actin (42 kDa) loading controls are provided for the 
cell lysate conditions. (d) Hexamer formation was quantified on the C99 signal (black arrow) for each of the 
mutations. The D23N (Iowa) mutation showed a significant increase in hexamer formation (**) compared to 
C99. One-way ANOVA with Tukey’s post hoc comparison where p =  < 0.01 (*), < 0.001 (**), < 0 (***). Error bars 
are expressed as ± SEM (N = 3). Images of full-length gels are presented in Supplemental Figures S8, S9, S10 for 
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mutations. In Fig. 1c (left panel), we show that in CHO cells transfected with the C99 sequence containing these 
mutations, there is the detection of hexameric Aβ in cell lysates. The hexamer is also detected in the media of 
A21G, E22K and D23N expressing cells (Fig. 1c, right panel). In particular, the D23N mutation shows a much 
more pronounced hexamer formation compared to any other mutant. This was confirmed by quantification of 
hexamer production in cell lysates normalised to the C99 signal (Fig. 1d) which shows that the D23N mutant 
generates significantly more hexameric Aβ than the wild-type C99 (p =  < 0.001), while all other mutants displayed 
similar levels of hexamer formation. Together, this demonstrates for the first time that hexameric Aβ is occurring 
in several AD-related conditions.
From these results, we can conclude that the formation of a hexameric assembly is a common feature in Aβ 
enriched conditions as well as in AD related Aβ mutations where amyloid formation is accelerated.
Isolation and composition of cell‑derived Aβ. As the aim of this study was to characterise the forma-
tion, self-assembly and possible nucleating properties of the hexamer, we next optimised the isolation of media 
derived hexameric Aβ. We have focussed here on Aβ material in the media as we hypothesise that the self-
assembly leading to the deposition of extracellular amyloid plaques is likely dependent on the presence of this 
hexamer in the extracellular space. To isolate the Aβ hexamer, CHO cells were transfected with C42 or C99 for 
48 h and media was immunoprecipitated using the W0-2 antibody. This was then separated using the Gel Eluted 
Liquid Fraction Entrapment Electrophoresis (GELFrEE) 8100 system. Briefly, as with SDS-PAGE, this system 
separates the peptide by size with the added advantage of collecting the assembly size of interest as a liquid frac-
tion. Shown in Fig. 2a, we confirm by western blotting the isolation of hexameric Aβ from the media of CHO 
cells transfected with C42 and C99 in fraction 5 only (C42 fraction 1–4 shown in Supplemental Figure S3). By 
isolating and characterising hexamers from both conditions, we are able to assess whether processing affects the 
self-assembly and nucleating properties of Aβ hexamers. We are also able to isolate C99-derived Aβ monomers 
in fraction 1, however, as lower molecular weight assemblies were not detectable in CHO cells transfected with 
C42, even when samples were harvested at earlier time points (Supplemental Figure S4), this was not possible 
for C42 transfected CHO cells. Considering the highly hydrophobic and aggregation prone nature of the Aβ42 
sequence, it is unsurprising that we cannot detect lower molecular weight assemblies which, if present, are likely 
too low in concentration to detect by western blotting.
To identify the isoform of Aβ in the C42 and C99-derived hexameric assemblies, we carried out dot blotting 
using anti-Aβ42 and anti-Aβ40 specific antibodies (Fig. 2b) with synthetic preparations of Aβ40 and Aβ42 as 
positive controls. Dot blotting with W0-2 (Fig. 2b, left panel) antibody was used to confirm the presence of the 
proteins. Our results clearly show the Aβ42 specific antibody binds to hexameric assemblies from both condi-
tions (Fig. 2b, right panel), although the signal for the C99- derived hexamer is less prominent. Importantly, no 
signal is seen for either hexamer with the Aβ40 specific antibody (Fig. 2b, middle panel), thus confirming the Aβ 
hexamers are Aβ42 assemblies. A dot blot with the anti-Cter antibody (Supplemental Figure S3) confirms that 
the isolated hexamers from C42 and C99 transfected CHO cells do not contain the CTF of APP.
The formation of a hexameric assembly is an inherent property of the Aβ42 peptide due to 
self‑assembly propensity. The preferential formation of hexameric Aβ has been suggested to be linked to 
the C-terminus of Aβ42 and its self-assembly  propensity23. To assess this in our cellular model, CHO cells were 
transfected with an assembly-impaired variant of the C42 sequence, vC42, and the Aβ profile was assessed by 
western blotting and detection with the W0-2 antibody (full primary sequence can be found in Supplemental 
Table S1). This is the same sequence that has been previously reported and thoroughly characterised as being 
self-assembly impaired despite only a two amino acid difference (F19S and G37D) compared to the wild-type 
Aβ42  sequence45. Figure 3 demonstrates that CHO cells transfected with this variant produced only dimers and 
trimers in the cell lysates and no detectable assemblies in the media. The lack of a hexameric assembly confirms 
the importance of self-assembly in the formation of this structure and its direct link to Aβ42 aggregation pro-
pensity.
Cell‑derived Aβ42 hexamer formation is a direct consequence of Aβ42 primary sequence. As 
both monomeric and hexameric Aβ were detected and isolated from C99 transfected cells, we next questioned 
whether the C99-derived Aβ monomers isolated in Fraction 1 (Fig. 2a) were able to assemble into hexamers. 
No assembly of the isolated Aβ monomers was seen by western blotting over 48 h, the time in which we see 
hexamer presence in the cell lysates and media of C42 and C99 transfected CHO cells (Fig. 4a). Electro-chemi-
luminescence immunoassay  (ECLIA) measurements, which provide quantitative analysis of monomeric Aβ, 
were performed on the media of C99 transfected CHO cells (Fig. 4b) before immunoprecipitation for Aβ and 
confirmed that Aβ40 was in high abundance (80.9 pg/mL) whereas very low concentrations of Aβ42 (1.3 pg/mL) 
were detected. This provided early indications that the monomer detected by western blot (Fig. 1a) is likely to be 
Aβ40. Analysis of the isolated monomer fraction by mass spectrometry (Fig. 4c) revealed that, in line with the 
reduced self-assembly properties reported in the  literature46, only the Aβ40 sequence was identified in this sam-
ple. Finally, we have confirmed by western blotting that Aβ40 is unable to form hexamers even in a cellular con-
text, as CHO cells transfected with C40 do not produce a detectable band for this assembly in either cell lysates or 
media (Fig. 1b). qPCR data consolidated that this was not due to low transfection efficiency (Supplemental S5).
Together, these data show for the first time from cell-derived material that Aβ40 does not readily form hexa-
meric assemblies, which in turn reinforces that the primary sequence of Aβ42 and its resultant self-assembly 
properties are determining factors in the formation of a hexameric assembly.
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Isolated hexameric Aβ42 does not self‑assemble into higher molecular weight assemblies. In 
order to establish the self-assembly properties of the isolated hexameric Aβ42 derived from media of C42 and 
C99 transfected CHO cells (Fraction 5 shown in Fig. 2a), we first carried out a ThT fluorescence assay as a meas-
ure of fibril formation. 150 µM of hexameric Aβ was incubated with 20 µM ThT and fluorescence was monitored 
over 48 h. Figure 5a shows that over this time course, there is no increase in fluorescence seen which suggests 
that the hexameric assembly does not form fibrils in the timeframe of our experiment. To further consolidate 
this and detect any pre-fibrillar assemblies that may not bind to the ThT dye, western blotting was carried out 
on the same samples at several time points (Fig. 5b and c). Detected by the W0-2 antibody, we see there are 
no higher molecular weight assemblies at longer time points and only the hexameric assembly is detected for 
C42-derived hexamers. This also confirms that there is no degradation or disassembly of the peptide. However, 
Figure 2.  Isolation of Aβ assemblies and identification of hexameric assembly Aβ isoform. (a) Aβ was 
immunoprecipitated using the W0-2 antibody and separated by size using the GELFrEE 8100 system. CHO cells 
transfected with the empty plasmid (EP) and immunoprecipitated for Aβ did not show isolated assemblies in 
any fraction. From C99 transfected CHO cells, we are able to isolate monomeric Aβ (orange box) in Fraction 
1 and hexameric Aβ (red box) in Fraction 5 (F5). Only hexameric Aβ was isolated (Fraction 5) from C42 
transfected CHO cells. (b) Dot blotting was carried out to identify the hexameric Aβ isoform using the W0-2, 
anti-Aβ40 and anti-Aβ42 antibodies. Synthetic Aβ40 and Aβ42 were used as positive controls. Both C42 and 
C99 derived Aβ hexamers are detected by the anti-Aβ W0-2 antibody (left panel) and anti-Aβ42 antibody (right 
panel), however, not by the anti-Aβ40 antibody (middle panel) confirming the hexamers are composed of Aβ42. 
Dashed border indicates the membrane was cut before detection.
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although C99-derived Aβ42 hexamers do not assemble into higher molecular weight assemblies, monomers 
are detected with increasing intensities over time. This suggests that in the C99 transfected conditions where 
processing is taking place, the hexamer is less stable and does disassemble into monomers. This is reflective of 
the dynamic nature of self-assembly, particularly in the formation of a critical nucleus. As we have identified the 
hexamers to be only composed of the Aβ42 isoform, these data also allow us to conclude that the monomers 
detected from the disassembled C99-derived hexamers are likely to be Aβ42 monomers. Combined, these data 
show no further self-assembly of hexameric Aβ assemblies derived from both C42 and C99 in our experimen-
tal conditions. We therefore conclude that these cell-derived hexameric assemblies have similar self-assembly 
properties in our experimental conditions; the hexamer on its own does not self-assemble into higher molecular 
weight assemblies, however, the stability of C99-derived Aβ42 hexamers is weaker than that of C42-derived 
Aβ42 hexamers.
Hexameric Aβ42 enhances self‑assembly of Aβ42 in the early stages of aggregation. Finally, 
we assessed the effect of Aβ42 hexamer addition on monomeric synthetic Aβ42 (mAβ42) aggregation with 
increasing amounts of isolated C42 and C99-derived Aβ42 hexamers (Fig. 6a). Aβ42 was prepared as previously 
 described45 using a protocol that has been shown to be predominantly monomeric immediately after prepara-
tion and diluted to a working stock concentration of 50 µM. ThT fluorescence of mAβ42 without any seeding 
(Supplemental Figure S6a) shows a low ThT fluorescence between 0–4 h. Based on the previous characterisation 
of Aβ42 self-assembly using this preparation  method45,47, we believe this early timeframe reflects the lag phase 
of aggregation. Between 4–16 h, there is a steep increase in ThT fluorescence which likely represents the elonga-
tion phase, as has been previously shown, and a plateau is reached after 16  h45,47,48. We show this aggregation 
to be concentration dependent in Supplemental S6b and used this data to decide upon 50 μM as our working 
concentration to carry out seeding experiments within a reasonable timeframe. The concentration of hexamer 
used for seeding was a percentage of the mAβ42 concentration and the final solution was incubated with 20 µM 
ThT dye. As the hypothesised nucleating effects of the hexamer are expected to be in the early stages of assembly, 
ThT fluorescence was monitored for 4 h and normalised for each condition to itself at T0 as a representation of 
increased fluorescence at each time point (Fig. 6a).
The addition of 5% (light pink line) and 10% (dark pink line) C42-derived hexamer immediately results in an 
increase in fluorescence intensity, as does the addition of 5% (light green line) C99-derived Aβ42 hexamer. This 
suggests increased self-assembly kinetics in the early stages of aggregation for these conditions, however, 10% 
(dark green line) addition of C99-derived Aβ42 hexamer results in a similar ThT fluorescence as mAβ42 alone 
Figure 3.  Hexamer formation is directly related to Aβ42 self-assembly propensity. CHO cells transfected 
with vC42 (F19S, G37D), did not form hexameric Aβ in either the cell lysates or media detected by the W0-2 
antibody. However, dimers (D) and trimers (T) were detected in the cell lysates of vC42 transfected CHO cells. 
Actin (42 kDa) loading controls are provided for the cell lysates conditions. Vertical dashed lines indicate that 
samples were run on the same gel, but lanes are not contiguous. Dashed border indicates the membrane was cut 
before detection. A full-length gel image of the media samples is presented in Supplemental Figure S11.
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(black line). This aggregation enhancing effect of the hexamers, particularly in the early time points, is shown 
with more clarity in Supplemental Figure S6c with additional data points between T0-4 h. Complementary to 
the ThT aggregation assay, we assessed the range of assembly sizes present at T0 and 2 h after hexamer addition 
by western blotting using the W0-2 antibody (Fig. 6c). By 2 h, both seeded conditions show the formation of a 
larger range of higher molecular weight assemblies which migrate as a smear, as well as bands detected in the 
well of the gel. As the detection of this band in the well is concomitant with the increase in ThT fluorescence, we 
believe that this band is likely to be fibrils ‘stuck’ in the well of the gel, however, electron microscopy is needed 
to confirm the presence of these fibrils. mAβ42 without seeding displays bands corresponding to monomers, 
dimers and trimers only. Western blotting for mAβ42 seeded with C99-derived Aβ42 hexamers (Fig. 6c) also 
revealed similar trends to that of C42-derived hexamer seeding where higher molecular weight assemblies were 
detected at T0 in the seeded conditions, and by 2 h, what likely corresponds to fibrils were ‘stuck’ in the wells of 
the gel. As we have identified both hexamers to be Aβ42, this is unsurprising. Interestingly, in contrast to what 
was seen with the ThT fluorescence, 10% addition of C99-derived Aβ42 hexamers does result in the formation 
of higher molecular weight assemblies by 2 h, perhaps suggesting the formation of ThT negative aggregates. 
Combined, the increase in ThT fluorescence seen in the seeded conditions, compared to non-seeded mAβ42 
only, supports the hypothesis of the hexamer as a nucleus for self-assembly.
Although our ThT assay is representative of qualitative analysis and is not suitable for quantitative kinetic 
analysis, we have calculated the gradient of the graph for each condition from 0–1 h for a numerical indication of 
effects on the early stages of aggregation (Fig. 6d). This analysis is to further consolidate the conclusion that Aβ42 
hexamer addition enhances self-assembly in the early stages of aggregation, however, interpretations cannot be 
made regarding the kinetics and microscopic steps of aggregation e.g., primary and secondary nucleation. The 
addition of 5% C42 and C99-derived hexamer significantly increases the gradient of the graph (0.51 AU ± 0.03 
SEM, 0.4AU ± 0.05 SEM respectively, p =  < 0.01) compared to mAβ42 alone (0.16 AU ± 0.05 SEM). Although an 
increase was also seen with 10% C42 hexamer (0.32 AU ± 0.1 SEM), this was not significant. This is likely due to 
the fact that the nucleating potential of the cell-derived C42 hexamer is dependent on the available monomers 
in solution. Furthermore, the same increase in early assembly kinetics was not seen with 10% C99-derived Aβ42 
seeding (0.1 AU ± 0.06 SEM). This might be due to the difference in stability of the C99-derived Aβ hexamer; 
as it disassembles into monomers with time (Fig. 4c), the concentration of monomers continues to dominate 
the solution population and there is perhaps not enough hexamer in solution to nucleate self-assembly, which 
indicates a threshold concentration is required before nucleating effects can be seen.
Finally, we also assessed the effects of both hexamers on monomeric Aβ40 (mAβ40) prepared using the same 
protocol as for mAβ42 (Fig. 7). Firstly, in non-seeded conditions, we show a reduced aggregation of 50 μM Aβ40 
compared to 50 μM Aβ42 in Supplemental Figure S6a, however we confirm that Aβ40 aggregation does occur 
across a range of concentrations in Supplemental Figure S6d. In seeded conditions, no increase in slope gradient 
at early time points (0–1 h) was seen for mAβ40 seeded with 5% and 10% C42 or C99-derived Aβ42 hexamers 
respectively. The lack of self-assembly enhancing effects at early stages of aggregation was further consolidated 
by western blotting (Fig. 7c) which revealed assembly sizes ranging from monomers to tetramers only for all 
conditions at T0 and 2 h, and no increase in higher molecular weight species. The ThT fluorescence for both 5 
and 10% C42-derived hexamer seeding does begin to slightly increase after 4 h which could be indicative of a 
reduced ability of these hexamers to nucleate Aβ40 compared to Aβ42. A similar and more pronounced trend of 
increased ThT fluorescence is seen with 5 and 10% C99-derived Aβ hexamers from 2 h onwards. Interestingly, 
as the increase in fluorescence was not seen in mAβ42 seeded with 10% C42-derived hexamers (Fig. 6) and as 
we have shown the C99-derived hexamers to disassemble into monomers, this data suggests some effect of two 
monomeric Aβ isoforms interacting.
Together, we conclude that the cell-derived Aβ42 hexamers have a reduced aggregation enhancing effect on 
Aβ40 which further reiterates the direct link of hexamers as likely critical nuclei for Aβ42 self-assembly. To be 
sure of this reduced capacity as opposed to inability, we seeded mAβ40 with 30% C42 and C99-derived hexamers 
(Supplemental Figure S7), which confirms that with enough hexamer, seeding can occur.
Our data demonstrate for the first time, the ability of cell-derived Aβ42 hexamers to enhance self-assembly 
in early stages of aggregation with preferential nucleation of monomeric Aβ42 compared to Aβ40.
Discussion
The process of self-assembly and its importance in Aβ toxicity has been the focus of several research studies. The 
formation of intermediary oligomeric species during this process has been identified as being a determinant of 
cytotoxicity and we therefore investigated an Aβ assembly that is hypothesised to be responsible for facilitat-
ing nucleation dependent amyloid formation. To the best of our knowledge, we are the first group to present 
a thorough characterisation of cell-derived hexameric Aβ and provide more physiologically relevant evidence 
than in vitro studies using synthetic or recombinant peptides, to further support this assembly to be a nuclea-
tion enhancing entity.
The identification of specific Aβ intermediate assemblies that serve as nuclei for fibril formation has remained 
elusive due to their transient and heterogenous nature. Despite this, several studies have optimised the use of 
highly sensitive techniques such as small angle neutron scattering (SANS), small angle X-ray scattering (SAX) and 
sedimentation velocity (SV) analysis complementary to SDS-PAGE of photo-induced cross linking of unmodified 
proteins (PICUP) solutions of Aβ to detect hexameric assemblies involved in the early stages of self-assembly26–28. 
Furthermore, a recent native ion mobility-mass spectrometry study has also identified the formation of hexam-
eric Aβ and suggests a β-barrel structure in membrane mimicking  environments49. In line with our data, these 
studies have all consistently observed the formation of hexameric Aβ to be highly prone to the Aβ42 sequence. 
However, these studies have relied heavily on synthetic peptides which cannot mimic a cellular environment. 
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Here, in our experimental conditions, we have identified a non-self-assembling Aβ42 specific hexamer that is 
present in both the cell lysates and media of transfected CHO cells.
CHO cells transfected with either C99 or C42 sequences showed the ability to form an Aβ assembly that 
was ~ 28 kDa in size by western blotting, which is the theoretical size of an Aβ42 hexamer. FAD Aβ mutations 
in the C99 sequence also showed the formation of hexameric Aβ in the cell lysates and media of CHO cells sug-
gesting that the formation of this assembly is common in Aβ enriched and FAD related conditions. The com-
monality of hexameric Aβ across these conditions highlights for the first time in a more physiological context, 
the importance of this assembly in conditions where Aβ self-assembly is accelerated.
Dot blotting following the isolation of these hexamers from the media of C42 and C99 transfected cells, 
confirmed them to be Aβ42 assemblies. On the contrary, the monomeric Aβ identified and isolated from the 
media of C99 transfected CHO cells was confirmed to be composed of the Aβ40 sequence only. Furthermore, this 
monomer did not assemble into hexamers or any other higher molecular weight assemblies in the parameters 
of our experiments. This information is important as it confirms that the ability to readily form a hexameric 
assembly in a cellular context is an inherent property of the Aβ42 primary sequence. This was further supported 
by the lack of a hexameric assembly seen in the cell lysates and media of CHO cells transfected with the vC42 
sequence which has both F19S and G37D substitutions. These substitutions have been shown to negatively affect 
self-assembly  propensity35,50–56. In this way, vC42 also begins to provide some evidence to suggest that both the 
F19 and G37 amino acids are important residues in the formation of a hexameric assembly. Interestingly, whilst 
this peptide was shown to remain largely monomeric for 7 days in vitro45 we show here in cellular context, the 
formation of dimers and trimers within 48 h. This further highlights the physiological relevance of our study 
in which we show the importance of protein translation, the cellular environment and the subsequent Aβ42 
assemblies formed.
Our data strongly supports the conclusion that the Aβ hexamers we have identified are Aβ42 specific assem-
blies. This, combined with the assumption that there are no other isoforms present in the C42 condition, as well 
as C99-derived hexameric Aβ disassembling back into monomers over time, suggests the initial nascent Aβ42 
monomer may be responsible for the formation of the Aβ42 hexameric structures identified here. A previous 
study exploring the decapeptide Aβ (21–30) showed its protease resistance was identical to full length of Aβ42 
and likely to organise intramolecular monomer folding and therefore an initial folding  nucleus57. This has been 
attributed to a β-turn formed and stabilised by both hydrophobic and electrostatic interactions between V24-K28 
and K28-E22/D23. FAD related mutations at positions G22 or D23 therefore disrupt this turn stability and have 
been shown to enhance subsequent assembly and  oligomerisation55,58,59. The level of turn disruption correlates 
directly with enhanced oligomerisation for each mutation; from our results, the D23N mutation significantly 
disrupts the turn stability and enhances the formation of hexameric Aβ42. The importance of this monomer 
folding nucleus in the formation of higher molecular weight assemblies, such as the hexamer, has been explained 
by the formation of the stabilised turn being a kinetically favoured folding event capable of facilitating the inter-
action between the central hydrophobic cluster (L17-A21) and the C-terminus, which is far more pronounced 
in Aβ42 than in Aβ4059. Together, this provides a plausible explanation as to (1) how the hexameric assembly is 
linked to folding events in the monomeric Aβ42 peptide (2) why FAD mutations explored in this study do not 
negatively affect hexamer  formation60. The disruption of the stabilising interactions in the decapeptide region 
of monomeric Aβ may occur in a physiological environment such an acidic pH (e.g. endosomes) where Aβ 
assembly is known to be enhanced.
We also show that hexameric assemblies that are formed from Aβ after C99 processing are less stable than 
those formed from C42 where there is no upstream processing, suggesting processing may have an effect on 
structural properties. Despite this, both hexamers display nucleating properties which points to size being an 
important contributor for nucleating potential. Interestingly, hexamers have also been identified as being impor-
tant intermediates in the self-assembly of β2-microglobulin which suggests this assembly size may play an 
important role in the aggregation of several amyloid forming  proteins61.
Several oligomeric species that are multimers of a hexameric unit e.g. ADDLs and Aβ*56, which would likely 
require hexameric self-association, have been identified. However, in the parameters of our experiments, the 
hexamer does not self-associate to form higher molecular weight assemblies. Hexamers with the ability to self-
associate may be in a different conformation and/or require suitable conditions for self-association such as 
membrane interactions or an acidic environment. Furthermore, the lack of association of two hexamers to form 
a dodecamer, which is thought to occur due to stacking of two hexamers with their hydrophobic C-terminal 
ends at the centre of the  structure22 was also observed by Ӧsterlund and colleagues. They concluded the reduced 
entropic drive towards hexamer dimerisation is likely due to the C-termini being stabilised in their experimental 
conditions which are likely mimicking the effects that would be seen in a lipid  bilayer49. Therefore, perhaps the 
Figure 4.  Hexamer formation is directly related to Aβ42 primary sequence. (a) Isolated monomeric Aβ 
incubated at room temperature over 48 h does not assemble into hexameric or other higher molecular 
weight assemblies as assessed by western blotting detected with the W0-2 antibody. A full-length gel image 
is presented in Supplemental Figure S12. (b) ECLIA measurements (N = 5) on the media of C99 transfected 
CHO cells identified Aβ40 as the most abundant monomeric Aβ isoform (80.9 pg/ml). Low concentrations 
of Aβ38 (24.7 pg/ml) and even lower concentrations of Aβ42 (1.3 pg/ml) were detected in this culture media 
(c) CLC-MS/MS identification of Aβ40 in the C99 Sample. Top left panel: extracted ion chromatogram of the 
[M + 2H]2 + detected at 62 min, for the standard (top) and the C99 sample (bottom). Top right Panel: mass 
spectra of the Aβ40 fragment ion showing the isotopic pattern for the standard (top) and the C99 sample 
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Figure 5.  Isolated hexameric Aβ does not self-assemble into higher molecular weight assemblies (a) 
150 µM isolated hexameric Aβ from C42 and C99 transfected CHO cells was incubated with 20 µM ThT and 
fluorescence was monitored over 48 h as a measure of fibrillogenesis. No increase in fluorescence was seen for 
either of the isolated hexamers. (b and c) Western blotting and detection with the W0-2-antibody revealed both 
hexamers (red box) do not assemble into higher molecular weight assemblies over 7 days. Hexamers from C99 
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Figure 6.  Isolated C42 and C99 derived hexameric Aβ nucleate monomeric Aβ42 (mAβ42). (a) 50 µM mAβ42 
was seeded with 5- or 10% hexamer and the solution was then incubated with 20 µM ThT. Fluorescence was 
monitored over 24 h. (b) Addition of both 5- and 10% C42 hexamer results in an immediate increase in ThT 
fluorescence (0–2 h). (c) Western blotting with the W0-2 antibody revealed all seeding conditions form higher 
molecular weight assemblies at T0 and by 2 h what likely correspond to fibrils are seen ‘stuck’ in the wells of the 
gel. Dashed borders indicate the membrane was cut before detection. (d) The gradient of the ThT fluorescence 
slope was calculated at the early time points of aggregation (0–1 h) and One-way ANOVA with Tukey’s post hoc 
comparison where p =  < 0.01 (*), < 0.001 (**), < 0 (***), revealed addition of 5% C42 hexamer significantly (**) 
increased the kinetics of aggregation compared to mAβ42 only as did the addition of 5% C99 derived hexamer 
(*). Error bars are expressed as ± SEM.
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Figure 7.  Isolated C42 and C99 derived hexameric Aβ do not readily nucleate monomeric Aβ40 (mAβ40). (a) 50 µM mAβ40 
was seeded with 5- or 10% hexamer and the solution was then incubated with 20 µM ThT. Fluorescence was monitored over 
4 h. (b) Addition of both 5- and 10% did not result in an increased fluorescence at early time points (0–2 h) (c) Western 
blotting detected with the W0-2 antibody revealed seeding conditions with both hexamers does not lead to the formation 
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hexamers we isolate here are or have been associated to these lipid bilayers which affects their self-association 
properties.
Importantly, we show for the first time the self-assembly enhancing potential of both C42 and C99 cell-derived 
hexamers and show this to be preferential to mAβ42 over mAβ40. Based on our data and literature surrounding 
Aβ hexamers, we believe that this is to be a nucleating effect. This likely nucleation propensity is heavily reliant 
on the available monomers in solution, in line with the definition of a nucleus for self-assembly during the lag 
phase of amyloid  formation21.
Overall, we demonstrate for the first time in a cellular context, the formation of hexameric Aβ42 as a common 
feature in conditions where Aβ42 self-assembly is accelerated and we have characterised these hexamers to be 
non-self-assembling entities that preferentially nucleate the aggregation of monomeric Aβ42. Understanding 
mechanisms that can enhance or facilitate self-assembly in this way will ultimately aid our understanding of 
amyloid pathology.
Materials and methods
Chemicals and reagents. Nitrocellulose membranes were purchased from GE Healthcare (Little Chalfont, 
UK) and Western Lightning Plus-ECL from PerkinElmer (Waltham, MA, USA). The anti-Aβ W0-2 (MABN10) 
primary antibody was from Abcam (Cambridge, UK), anti-Aβ40 and anti-Aβ42 primary antibodies were pur-
chased from Merck Millipore (Darmstadt, Germany). The anti-Cter primary antibody and horse radish peroxi-
dase (HRP)-conjugated secondary antibodies were purchased from Sigma-Aldrich (St Louis, MO, USA). TRIzol 
reagent and Complete protease inhibitor cocktail were from Roche (Basel, Switzerland). The cDNA synthesis kit 
and iQ SYBR Green Supermix were from Bio‐Rad (Hercules, CA, USA).
DNA constructs. The pSVK3 empty plasmid (EP) as well as the -C40, -C42 and -C99 vectors including the 
fused signal peptide of APP were described  previously43,62. QuickChange site-specific mutagenesis (Stratagene, 
La Jolla, CA, USA) was used to produce the FAD mutants in the pSVK3-C99 template DNA, as previously 
 described63. Primer sequences can be found in Supplemental Table S2.
Cell culture and transfection. Chinese hamster ovary (CHO) cell lines were cultured in Ham’s F-12 
medium supplemented with 10% of FBS and 1% Penicillin–Streptomycin (Life Technologies, Carlsbad, CA, 
USA). All cell cultures were maintained at 37 °C in a humidified atmosphere (5%  CO2). Cells were passed every 
4 days at ~ 80% confluency and no longer used after passage 20.
For transfections with C99 and Aβ sequences, approximately 2.2 ×  106 CHO cells were plated 24 h in advance 
in 10 cm petri dishes. A transfection mix of 15 µg of DNA, 30 µl Lipo2000 (Invitrogen) in 1 ml Opti-MEM was 
incubated for 15 min at room temperature before being added to cells. A 0% FBS medium change was carried 
out 24 h after transfection and both cells and media were harvested after 48 h of initial transfection.
Western and dot blotting. After transfection, cell lysates were harvested and sonicated in lysis buffer (Tris 
125 mM pH 6.8, 4% sodium dodecyl sulfate, 20% glycerol) with Complete protease inhibitor cocktail. Media 
were centrifuged at 1200 g for 5 min to pellet any debris and dead cells and the supernatants were lyophilised by 
SpeedVac. For cell lysates, 40 µg of protein were heated for 10 min at 70 °C in loading buffer (lysis buffer sup-
plemented with 50 mM DTT and LDS sample buffer). The lyophilised media were resuspended in 400 µl milli-
Q (mQ) water and the maximum sample volume was loaded. Samples were loaded and separated on 4–12% 
NuPAGEbis‐tris gels (Life Technologies), and then transferred for 2 h at 30 V onto 0.1 µm nitrocellulose mem-
branes. After 30 min of blocking (5% non‐fat milk in 0.1% PBS-Tween), membranes were incubated at 4 °C over-
night with primary antibodies. Membranes were then washed three times in 0.1% PBS-Tween for 10 min and 
incubated with horse radish peroxidase (HRP)-conjugated secondary antibodies for 1 h at room temperature. 
Finally, membranes were again washed three times for 10 min in PBS-Tween prior to ECL detection. Membranes 
were stripped with boiling 1X PBS for 10 min before being re-detected with the anti-Actin antibody. Primary 
antibodies dilutions for western blotting are as follows: anti‐Aβ W0-2 (1:1.500), anti‐Cter (1:2.000) and anti-
Actin (1:1000). Secondary antibodies dilutions are as follows: anti‐mouse (1:10.000) or anti‐rabbit (1:10.000). 
Both primary and secondary antibodies were diluted in 0.1% PBS-Tween.
For dot blotting, 5 µl of sample (150 µM isolated Aβ hexamers, 50 µM synthetic monomeric Aβ) were spotted 
onto 0.1 µm nitrocellulose membranes. Once the samples were dry, a further 5 µl of sample were spotted twice 
on top and dried. The membranes were boiled in PBS for 3 min twice and blocked in 5% non-fat milk in PBS-
Tween for 30 min. After this the membranes were washed, incubated with antibodies and detected with ECL as 
described above. Primary antibodies dilutions for dot blotting are as follows: anti‐Aβ W0-2 (1:1.500), anti‐Aβ40 
(1:1.000), anti‐Aβ42 (1:1.000). Secondary antibodies dilutions are as follows: anti‐mouse (1:10.000) or anti‐rabbit 
(1:10.000). Both primary and secondary antibodies were diluted in 0.1% PBS-Tween.
For native gels, the samples were harvested and prepared in native sample buffer and run on Novex Tris–Gly-
cine gels (ThermoFisher) in native running buffer as per the manufacturer’s instructions (https:// www. therm 
ofish er. com/ uk/ en/ home/ life- scien ce/ prote in- biolo gy/ prote in- gel- elect ropho resis/ prote in- gels/ novex- tris- glyci 
ne- gels. html). From here, the transfer and detection of the membrane were as described above. Membranes were 
detected with the W0-2 and anti-Cter antibodies at the same dilutions stated above.
Full-length images of cropped gels presented in the main figures are provided in the Supplemental Data 
file. We have highlighted instances in which the membrane was cut prior to antibody binding and detection, 
particularly in the case of Actin detections. Regardless, we still provide the full-length original images of the 
samples presented in the main figures.
14
Vol:.(1234567890)
Scientific Reports |        (2021) 11:11570  | https://doi.org/10.1038/s41598-021-90680-y
www.nature.com/scientificreports/
Isolation of Aβ assemblies: gel eluted liquid fraction entrapment electrophoresis (GEL‑
FrEE). 6.6 ×  106 CHO cells were seeded in T175 flasks 24 h before transfection. Cells were transfected with 
45 µg of DNA using Lipofectamine 2000 and a 0% FBS medium change was carried out 24 h after transfection. 
The media were harvested and lyophilised 48 h after initial transfection and resuspended in 1 ml milli-Q water. 
Aβ was immunoprecipitated using Sepharose A beads (Invitrogen) coated with the anti-Aβ W0-2 antibody. For 
immunoprecipitation, 100 µl recombinant Sepharose A beads (50 mg/ml) were incubated with the medium for 
3 h as a pre-clearing step. This was then centrifuged at > 15.000 g for 5 min and the beads were discarded. The 
supernatant was next incubated with 5 µl W0-2 antibody for 1 h at 4 °C, after which 100 µl fresh Sepharose beads 
were added and incubated at 4 °C overnight. The beads were then washed 3 times with mQ water and resus-
pended in 104 µl mQ water, 16 µl of DTT 0.5 M and 30 µl Tris–Acetate loading buffer. The mixture was boiled 
at 95 °C for 10 min and centrifuged at > 15.000 g for 5 min. The supernatant was loaded into the GELFrEE 8100 
system and run using the following method; Step 1- 16 min at 50 V, Step 2- 40 min at 50 V (Monomer fraction), 
Step 3- 4 min at 50 V, Step 4- 6 min at 70 V, Step 4- 13 min at 85 V and Step 6- 38 min at 85 V (Hexamer Fraction).
Samples were collected in the system running buffer (1X buffer; 1% HEPES, 0.01% EDTA, 0.1% SDS and 
0.1% Tris) and kept on ice. The monomeric fraction was then put through a buffer equilibrated 7 K MWCO Zeba 
buffer-exchange column (Thermo Scientific) to remove the Tris–Acetate blue sample buffer. The absorbance at 
280 nm was read using a BioPhotometer D30 (Eppendorf) and the concentration of the collected Aβ assemblies 
were calculated using the molecular coefficient of 1490 M-1 cm-1; (A280/1490) × 1000 × 1000.
For assembly over time experiments, monomeric and hexameric samples were incubated at room temperature 
and 20 µl aliquots were taken for western blotting at each time point.
ECLIA. Quantification of Aβ38, Aβ40, and Aβ42 monomeric peptides in the serum free media of C99 trans-
fected CHO cells was achieved using the Aβ multiplex electro-chemiluminescence immunoassay (ECLIA; Meso 
Scale Discovery, Gaithersburg, MD, USA) as previously  described64. Aβ were quantified with the human Aβ 
specific 6E10 multiplex assay according to the manufacturer’s instructions.
Synthetic monomeric Aβ preparation and seeding. Monomeric solutions of Aβ were prepared as 
previously  described45,47. Briefly, recombinant Aβ40 and Aβ42 were purchased from rPeptide as 1,1,1,3,3,3-Hex-
afluoro-2-propanol (HFIP) films. 0.2 mg aliquots of peptide were solubilised in 200 μl HFIP (Sigma-Aldrich) 
to disaggregate any preformed aggregates. The solution was then vortexed for 1 min and sonicated in a water 
bath for 5 min. The HFIP was then dried off using a steady flow of nitrogen gas. 200 μl of anhydrous dimethyl 
sulfoxide (DMSO) (Sigma-Aldrich) was then added and the solution was vortexed for 1 min. The solution was 
then put through a buffer equilibrated 7 K MWCO Zeba buffer-exchange column (Thermo Scientific) at 4 °C. 
The protein solution was then kept on ice whilst the absorbance at 280 nm was measured using a BioPhotom-
eter D30 (Eppendorf) spectrophotometer. The concentration was calculated using the molecular coefficient of 
1490 M-1 cm-1; (A280/1490) × 1000 × 1000. Solutions were immediately diluted to 50 μM in buffer and this was 
taken to be the new working stock.
ThT assay. To assess the self-assembly of the isolated hexameric Aβ, the fluorescence of 20 μM ThT (Sigma-
Aldrich) in 150 μM isolated hexamer was measured over 48 h in 96 well plates using the VICTOR Multilabel 
Plate Reader (PerkinElmer, Waltham, MA, USA). For seeding experiments, fluorescence of 20 μM ThT in 50 µM 
monomeric Aβ40 or Aβ42 was monitored over 24 h. Fluorescence readings were obtained at room temperature 
with excitation and emission wavelengths set at 460 nm and 483 nm respectively.
Mass spectrometry. The fractions of the cellular samples from the GELFrEE system were passed through 
HiPPR Detergent Removal 0.1 ml columns (ThermoFisher Scientific), previously equilibrated with a 25 mM 
ammonium bicarbonate  (NH4HCO3) solution, to remove the detergent from the solution. The samples were 
centrifuged for 2 min at 1500 g, then lyophilised.
Samples were then resuspended in 50 mM ammonium bicarbonate before being first reduced (10 mM dithi-
othreitol) for 40 min at 56 °C, alkylated (20 mM iodoacetamide) for 30 min at room temperature, and finally 
digested with trypsin for 16 h at 37 °C (1/50 w/w enzyme/proteins ratio). Reactions were stopped by acidifying 
the solution using 10% TFA. Generated peptides were then analyzed by LC–MS/MS.
Peptides were separated by reversed-phase chromatography using Ultra Performance Liquid Chromatog-
raphy (UPLC-MClass, HSS T3 column, Waters, Milford, MA, USA) in one dimension with a linear gradient of 
acetonitrile (5 to 40% in 70 min, solvent A was water 0.1% formic acid, solvent B was acetonitrile 0.1% formic 
acid) at a 600 nl/min flow rate. The chromatography system was coupled with a Thermo Scientific Q Exactive 
Plus hybrid quadrupole-Orbitrap mass spectrometer (ThermoFisher Scientific, Waltham, MA, USA), with a 
targeted method. The targeted masses are the m/z of the three following doubly charged peptides, that result 
from the trypsin digestion: LVFFAEDVGSNK m/z 663.3404, GAIIGLMVGGVV m/z 543.3230 and GAIIGLM-
VGGVVIA m/z 635.3836.
Full-MS scans were acquired at 70.000 mass resolving power (full width at half maximum). A mass range 
from 400 to 1750 m/z was acquired in MS mode, and 3 ×  106 ions were accumulated. Ion trap Higher energy 
Collision Dissociation fragmentations at NCE (Normalized Collision Energy) 25 were performed within 2amu 
isolation windows.
Raw MS files were analyzed by Proteome Discoverer 2.1.1.21 software (Thermo Scientific). MS/MS spectra 
were compared to the Uniprot Cricetulus griseus protein database, in which had been added the sequence of 
two main human amyloid peptides Aβ40 and Aβ42. Due to this restricted length in amino acids, the criteria for 
identification of each protein has been set up to one unique peptide per protein. The false discovery rate (FDR) 
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was set to 0.01 on both protein and peptide levels. The tolerance on mass accuracy was set at 5 ppm (10 ppm 
for MS/MS).
qPCR. RNAs were extracted from cells in TRIPure reagent and reverse‐transcribed using an iScript cDNA 
synthesis kit. qPCR conditions were 95 °C for 30secs, followed by 40 cycles of 30secs at 95 °C, 45secs at 60 °C 
and 15secs at 79 °C and ended by 1 cycle of 15secs at 79 °C and 30secs at 60 °C. The relative changes in the target 
gene‐to‐GAPDH mRNA ratio were determined by the  2(−ΔΔCt) calculation. The sequences for qPCR primers are 
provided in Supplemental Table S3.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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